Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04040322
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 198
Not applicableStudy completedNCT02212249
What this trial is testing

Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis

Who this might be right for
Primary Raynaud DiseaseSystemic Sclerosis
University Hospital, Grenoble 85
Not applicableWithdrawnNCT03393325
What this trial is testing

Tadalafil-Delivra and Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Testing effectiveness (Phase 2)UnknownNCT02356809
What this trial is testing

Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon

Who this might be right for
Secondary Raynaud's Phenomenon
Artgen Biotech 30
Testing effectiveness (Phase 2)Study completedNCT02260557
What this trial is testing

Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Actelion 74
Not applicableStudy completedNCT00822354
What this trial is testing

Tadalafil for the Treatment of Raynaud's

Who this might be right for
Raynaud
Northwestern University 10
Not applicableUnknownNCT04015193
What this trial is testing

Follow-up of SPTS in Patients With Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Medical Center Groningen 50
Post-approval studies (Phase 4)Ended earlyNCT03639766
What this trial is testing

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University of Central Florida 3
Not applicableUnknownNCT03749577
What this trial is testing

Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 30
Not applicableStudy completedNCT03129178
What this trial is testing

Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University of Portsmouth 27
Not applicableStudy completedNCT04854850
What this trial is testing

Apollo Device for Fatigue in Systemic Sclerosis

Who this might be right for
Systemic SclerosisFatigueRaynaud Phenomenon
Robyn T. Domsic, MD, MPH 25
Large-scale testing (Phase 3)Study completedNCT03717961
What this trial is testing

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 91
Post-approval studies (Phase 4)Study completedNCT00048776
What this trial is testing

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Otsuka America Pharmaceutical 75
Not applicableUnknownNCT04650659
What this trial is testing

Functional Exercise Tests in Patients With Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicLung Diseases, InterstitialPulmonary Arterial Hypertension+1 more
University of Aarhus 83
Not applicableStudy completedNCT01743612
What this trial is testing

Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.

Who this might be right for
Raynaud DiseaseScleroderma, Systemic
University Hospital, Grenoble 101
Large-scale testing (Phase 3)Study completedNCT00419419
What this trial is testing

Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseSclerodermaAutoimmune Diseases
MediQuest Therapeutics 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07759557
What this trial is testing

Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon

Who this might be right for
Systemic Sclerosis (SSc)Raynaud Disease Secondary to Scleroderma
Khon Kaen University 72
Early research (Phase 1)Study completedNCT00841594
What this trial is testing

MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison

Who this might be right for
Raynaud's Phenomenon
MediQuest Therapeutics 12
Large-scale testing (Phase 3)UnknownNCT00934427
What this trial is testing

Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

Who this might be right for
Raynaud Disease
MediQuest Therapeutics 100
Not applicableWithdrawnNCT04898036
What this trial is testing

Phototherapy For Treatment Of Raynaud's Phenomenon

Who this might be right for
Raynaud DiseaseRaynaud PhenomenonRaynaud Syndrome
University of Minnesota
Next Page